Estimating long-term vaccine effectiveness against SARS-CoV-2 variants: a model-based approach

With the ongoing evolution of the SARS-CoV-2 virus updated vaccines may be needed. We fitted a model linking immunity levels and protection to vaccine effectiveness data from England for three vaccines (Oxford/AstraZeneca AZD1222, Pfizer-BioNTech BNT162b2, Moderna mRNA-1273) and two variants (Delta,...

Descripción completa

Detalles Bibliográficos
Autores principales: Hogan, Alexandra B., Doohan, Patrick, Wu, Sean L., Mesa, Daniela Olivera, Toor, Jaspreet, Watson, Oliver J., Winskill, Peter, Charles, Giovanni, Barnsley, Gregory, Riley, Eleanor M., Khoury, David S., Ferguson, Neil M., Ghani, Azra C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356855/
https://www.ncbi.nlm.nih.gov/pubmed/37468463
http://dx.doi.org/10.1038/s41467-023-39736-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356855/
https://www.ncbi.nlm.nih.gov/pubmed/37468463
http://dx.doi.org/10.1038/s41467-023-39736-3

Ejemplares similares